COVID-19 Drugmaker Eli Lilly Appoints New Compliance Chief
Pharmaceutical giant and COVID-19 antibody therapy maker Eli Lilly and Co. named a new chief ethics and compliance officer Tuesday to head up the Indiana-based company's global risk management operations....To view the full article, register now.
Already a subscriber? Click here to view full article